Mauna Kea Technologies SA

OTCPK:MKEA.F Stock Report

Market Cap: US$24.8m

Mauna Kea Technologies Past Earnings Performance

Past criteria checks 0/6

Mauna Kea Technologies has been growing earnings at an average annual rate of 16.9%, while the Medical Equipment industry saw earnings growing at 8.7% annually. Revenues have been growing at an average rate of 5.6% per year.

Key information

16.9%

Earnings growth rate

27.6%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate5.6%
Return on equityn/a
Net Margin-33.8%
Next Earnings Update26 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Mauna Kea Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:MKEA.F Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2311-4114
30 Sep 2311-3114
30 Jun 2312-2114
31 Mar 2310-7114
31 Dec 228-11114
30 Sep 228-12124
30 Jun 228-13144
31 Mar 228-13143
31 Dec 219-13143
30 Sep 218-13143
30 Jun 218-13133
31 Mar 218-13143
31 Dec 207-13143
30 Sep 207-13153
30 Jun 207-14153
31 Mar 208-15153
31 Dec 199-15163
30 Sep 199-15154
30 Jun 199-14144
31 Mar 199-13145
31 Dec 188-13135
30 Sep 188-12125
30 Jun 187-11114
31 Mar 188-11114
31 Dec 178-10114
30 Sep 178-10124
30 Jun 178-11124
31 Mar 179-10124
31 Dec 1610-10124
30 Sep 1610-10134
30 Jun 1610-10134
31 Mar 1610-11154
31 Dec 1510-13165
30 Sep 1511-13175
30 Jun 1512-14175
31 Mar 1512-14185
31 Dec 1412-14185
30 Sep 1412-13174
30 Jun 1411-12164
31 Mar 1411-12164
31 Dec 1311-12164
30 Sep 1311-12164
30 Jun 1311-13174

Quality Earnings: MKEA.F is currently unprofitable.

Growing Profit Margin: MKEA.F is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MKEA.F is unprofitable, but has reduced losses over the past 5 years at a rate of 16.9% per year.

Accelerating Growth: Unable to compare MKEA.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MKEA.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.4%).


Return on Equity

High ROE: MKEA.F's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/06/18 02:15
End of Day Share Price 2024/03/21 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mauna Kea Technologies SA is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Guillaume CuvillierGilbert Dupont
Stephanie LefebvreGilbert Dupont
Sachin SoniKempen & Co. NV